Overall rank by patents
#3,655
Across all tracked assignees
USPTO PatentsView assignee record - 100 granted patents across 40 technology areas, active 2015–2025. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: A61K (PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES).
The verdict
GE holds 100 US patents across 40 technology areas, rank #3,655 of 50,000 tracked assignees.
GE Healthcare Limited has been granted 100 US utility patents between 2015 and 2025, placing GE Healthcare Limited at rank #3,655 across all assignees tracked by PlainPatent. This portfolio spans 40 distinct Cooperative Patent Classification (CPC) subclasses, averaging 13.7 claims per patent with primary concentration in A61K (PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES). As a Foreign Corporation, GE Healthcare Limited is one of the more focused assignees in the PatentsView dataset. By volume, GE sits between Casio Keisanki Kabushiki Kaisha (100 patents, rank #3,651) and Litens Automotive Partnership (100 patents, rank #3,659) - the closest US assignees by grant volume. The composite Innovation Score of 48.6/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.
Filing cadence tells the strategic story. Between 2020 and 2025 the company received 31 grants, compared with 69 in the 2015–2019 window, a -55% shift in five-year velocity. A cooling filing rate may reflect portfolio consolidation, shifting priorities, or reduced R&D throughput. The Foreign Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.
Claim depth and technology breadth together indicate competitive posture. GE Healthcare Limited's 13.7 average claims per patent sits within the typical range for solid legal coverage without excessive prosecution cost, while a multi-domain presence across 40 subclasses balances depth with breadth. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark GE Healthcare Limited against peers pursuing similar technology classes.
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
CASIO KEISANKI KABUSHIKI KAISHA
100 patents
CHARGEPOINT, INC.
100 patents
FCA Italy S.p.A.
100 patents
Forescout Technologies, Inc.
100 patents
HUAWEI TECHNOLOGIES CANADA CO., LTD.
100 patents
Kingston Digital, Inc.
100 patents
LABORATORY CORPORATION OF AMERICA HOLDINGS
100 patents
LITENS AUTOMOTIVE PARTNERSHIP
100 patents
GE HEALTHCARE LIMITED
100 patents
What this shows GE holds 100 patents at rank #3,655, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
By rank, the assignees closest to #3,655 in granted patent volume.
Other assignees with the most granted patents in GE's primary technology class.
GE's Innovation Score vs. every tracked assignee
Composite of portfolio volume, filing velocity, technology breadth, and claim depth (0–100)
49 Top 16% higher than 84% of 50,000 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2015 | 20 | 20.0% |
| 2016 | 18 | 18.0% |
| 2017 | 10 | 10.0% |
| 2018 | 11 | 11.0% |
| 2019 | 10 | 10.0% |
| 2020 | 12 | 12.0% |
| 2021 | 7 | 7.0% |
| 2022 | 5 | 5.0% |
| 2023 | 2 | 2.0% |
| 2024 | 2 | 2.0% |
| 2025 | 3 | 3.0% |
Top 15 of 40 technology areas
Overall rank by patents
#3,655
Across all tracked assignees
48.6 out of 100
How to use this portfolio
GE's 100 grants land it in the top 16% by Innovation Score, but volume alone doesn't tell you where the strength sits.
Patent counts and the Innovation Score measure patenting activity, not commercial success or the legal strength of any patent. Many patents are filed defensively. Verify the status of an individual patent against official USPTO records.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.